Register
|
Accessibility
|
Contact us
|
Login
Add PDF to basket
My basket
skip to main content
Search our Site
Keywords
Menu
Close
Home
ELMMB Formulary
Medicines Index Search
9.0 Nutrition and blood
1.0 Gastrointestinal
10.0 Musculoskeletal and joint diseases
2.0 Cardiovascular
11.0 Eye
3.0 Respiratory
12.0 Ear, Nose and Oropharynx
4.0 Central Nervous System
13.0 Skin
5.0 Infections
14.0 Immunological Products and Vaccines
6.0 Endocrine
15.0 Anaesthesia
7.0 Obstetrics, gynaecology & urinary-tract disorders
Black Traffic Light Drugs (Not Recommended for Use)
8.0 Malignant Disease and Immunosuppression
NICE Guidance
Specialist Formulary
Antimicrobial Guidelines for Primary Care
High Cost Drugs exc from tariff
Joint Continence & Catheter Care Formulary
Lancashire and South Cumbria Wound Care Formulary
Out-of-Hours Formulary
Secondary Care Guidelines for Management of Infections in Adults
Specialist Skin Formulary
Stoma and Continence Products
Policies & Guidelines
Guidelines
NICE Visual Summaries: Antimicrobial Prescribing
Palliative Care & Syringe Drivers
Patient Group Directions
Policies for the Commissioning of Healthcare
Research, Innovation and Clinical Effectiveness
Shared Care Guidelines
Sip Feed Guidelines & Food First Resources
ELMMB Information
Prescribing Hot Topics Newsletters
NICE Bites Bulletins
MHRA Drug Safety Updates
Medicines Management Board Minutes
Drug Alerts and Withdrawals
ELMMB Updates
ELMMB Forms
Stock Updates
Electronic Repeat Dispensing
Covid-19 Information and Resources
Resource Centre
Appliance Prescription Service
Care Home Resource Pages
Community Pharmacy
Cost Effective Prescribing
E-learning Hub
FLU INFORMATION
Gluten Free Information
Information for Patients
NHS Digital Weight Management Programme
Non-Medical Prescribing
Pain Management
Self-Care Information
Structured Diabetes Education
1.2 ANTISPASMODICS AND OTHER DRUGS ALTERING GUT MOTILITY
1.2 Antispasmodics and other drugs altering gut motilit
Useful as adjunctive treatment in non-ulcer dyspepsia, irritable bowel syndrome and diverticular disease, to reduce
intestinal
motility.
GREEN
Mebeverine capsules 200mg
(Colofac
®
MR)
GREEN
Mebeverine tablets135mg
(prescribe as Colofac
®)
GREEN
Alverine Citrate capsules 60mg
GREEN
Hyoscine butylbromide
tablets 10mg,
injection 20mg/mL *WARNING
see link below*
*Drug Safety Update*
serious adverse effects in patients with underlying cardiac disease
GREEN
Peppermint oil e/c capsules
RED
Peppermint water
AMBER
Dicycloverine 10mg/5mL oral solution. [
Use restricted to paediatrics only, for continuation when initiated
by tertiary centres.]
Metoclopramide and domperidone stimulate gastric emptying, small intestinal transit and enhance strength of oesophageal
sphincter contraction.
Avoid metoclopramide in children and those under 20 years of age because of the risk of dystonic
reactions.
GREEN
Domperidone
-
see section 4.6
GREEN
Metoclopramide
-
see section 4.6
Eluxadoline
is recommended as an option in treating irritable bowel syndrome with
diarrhoea in adults as per
NICE guidance TA471
RED
Eluxadoline tablets 75mg, 100mg
(Truberzi®)
BACK to main chapter
Home
ELMMB Formulary
Joint medicines formulary
Medicines index search
1.0 Gastrointestinal
1.2 Antispasmodics and other drugs affecting motility
2.0 Cardiovascular
3.0 Respiratory
4.0 Central Nervous System
5.0 Infections
6.0 Endocrine
7.0 Obstetrics, gynaecology & urinary-tract disorders
8.0 Malignant Disease and Immunosuppression
9.0 Nutrition and blood
10.0 Musculoskeletal and joint diseases
11.0 Eye
12.0 Ear, nose and oropharynx
13.0 Skin
14.0 Immunological Products and Vaccines
15.0 Anaesthesia
Appendix 6 - Medicines not classified in the BNF – Imported or Unlicensed Products
My Basket